331 related articles for article (PubMed ID: 21323799)
21. Unfavourable cardiovascular disease risk profiles in a cohort of Dutch and British haemophilia patients.
Fransen van de Putte DE; Fischer K; Makris M; Tait RC; Chowdary P; Collins PW; Meijer K; Roosendaal G; Schutgens RE; Mauser-Bunschoten EP
Thromb Haemost; 2013 Jan; 109(1):16-23. PubMed ID: 23138324
[TBL] [Abstract][Full Text] [Related]
22. Leukocyte count as a predictor of cardiovascular events and mortality in postmenopausal women: the Women's Health Initiative Observational Study.
Margolis KL; Manson JE; Greenland P; Rodabough RJ; Bray PF; Safford M; Grimm RH; Howard BV; Assaf AR; Prentice R;
Arch Intern Med; 2005 Mar; 165(5):500-8. PubMed ID: 15767524
[TBL] [Abstract][Full Text] [Related]
23. Established cardiovascular disease and CVD risk factors in a primary care population of middle-aged Irish men and women.
Creagh D; Neilson S; Collins A; Colwell N; Hinchion R; Drew C; O'Halloran D; Perry IJ
Ir Med J; 2002; 95(10):298-301. PubMed ID: 12542011
[TBL] [Abstract][Full Text] [Related]
24. Prevalence of modifiable cardiovascular risk factors in German adolescents.
Müller-Riemenschneider F; Nocon M; Willich SN
Eur J Cardiovasc Prev Rehabil; 2010 Apr; 17(2):204-10. PubMed ID: 19996972
[TBL] [Abstract][Full Text] [Related]
25. Impact of the metabolic syndrome on mortality from coronary heart disease, cardiovascular disease, and all causes in United States adults.
Malik S; Wong ND; Franklin SS; Kamath TV; L'Italien GJ; Pio JR; Williams GR
Circulation; 2004 Sep; 110(10):1245-50. PubMed ID: 15326067
[TBL] [Abstract][Full Text] [Related]
26. [Cardiovascular risk in hemodialysis in Spain: prevalence, management and target results (MAR study)].
Portolés J; López-Gómez JM; Aljama P
Nefrologia; 2005; 25(3):297-306. PubMed ID: 16053011
[TBL] [Abstract][Full Text] [Related]
27. Cardiovascular risk factor prevalence among men in a large industry of northern India.
Prabhakaran D; Shah P; Chaturvedi V; Ramakrishnan L; Manhapra A; Reddy KS
Natl Med J India; 2005; 18(2):59-65. PubMed ID: 15981439
[TBL] [Abstract][Full Text] [Related]
28. Relation of borderline peripheral arterial disease to cardiovascular disease risk.
Menke A; Muntner P; Wildman RP; Dreisbach AW; Raggi P
Am J Cardiol; 2006 Nov; 98(9):1226-30. PubMed ID: 17056334
[TBL] [Abstract][Full Text] [Related]
29. Alarmingly high prevalence of obesity in haemophilia in the state of Mississippi.
Majumdar S; Morris A; Gordon C; Kermode JC; Forsythe A; Herrington B; Megason GC; Iyer R
Haemophilia; 2010 May; 16(3):455-9. PubMed ID: 20148981
[TBL] [Abstract][Full Text] [Related]
30. Prevalence and risk factors for heart disease among males with hemophilia.
Kulkarni R; Soucie JM; Evatt BL;
Am J Hematol; 2005 May; 79(1):36-42. PubMed ID: 15849761
[TBL] [Abstract][Full Text] [Related]
31. Non-aspirin NSAIDs, cyclooxygenase-2 inhibitors and risk for cardiovascular events-stroke, acute myocardial infarction, and death from coronary heart disease.
Roumie CL; Choma NN; Kaltenbach L; Mitchel EF; Arbogast PG; Griffin MR
Pharmacoepidemiol Drug Saf; 2009 Nov; 18(11):1053-63. PubMed ID: 19637402
[TBL] [Abstract][Full Text] [Related]
32. [Coronary heart disease risk factors in Croatia and worldwide: results of the Interheart study].
Carević V; Rumboldt M; Rumboldt Z;
Acta Med Croatica; 2007 Jun; 61(3):299-306. PubMed ID: 17629106
[TBL] [Abstract][Full Text] [Related]
33. Hypertension, concurrent cardiovascular risk factors and mortality: the Singapore Cardiovascular Cohort Study.
Lee J; Ma S; Heng D; Chew S; Hughes K; Tai E
J Hum Hypertens; 2008 Jul; 22(7):468-74. PubMed ID: 18337755
[TBL] [Abstract][Full Text] [Related]
34. Hypertension and cardiovascular diseases in Swedish persons with haemophilia - A longitudinal registry study.
Lövdahl S; Henriksson KM; Baghaei F; Holmström M; Berntorp E; Astermark J
Thromb Res; 2019 Sep; 181():106-111. PubMed ID: 31386935
[TBL] [Abstract][Full Text] [Related]
35. Association between prehypertension and clustering of cardiovascular disease risk factors among Chinese adults.
Yu D; Huang J; Hu D; Chen J; Cao J; Li J; Gu D
J Cardiovasc Pharmacol; 2009 May; 53(5):388-400. PubMed ID: 19454899
[TBL] [Abstract][Full Text] [Related]
36. Low CD4+ T cell count is a risk factor for cardiovascular disease events in the HIV outpatient study.
Lichtenstein KA; Armon C; Buchacz K; Chmiel JS; Buckner K; Tedaldi EM; Wood K; Holmberg SD; Brooks JT;
Clin Infect Dis; 2010 Aug; 51(4):435-47. PubMed ID: 20597691
[TBL] [Abstract][Full Text] [Related]
37. Metabolic syndrome in Portugal: prevalence and implications for cardiovascular risk--results from the VALSIM Study.
Fiuza M; Cortez-Dias N; Martins S; Belo A;
Rev Port Cardiol; 2008 Dec; 27(12):1495-529. PubMed ID: 19280993
[TBL] [Abstract][Full Text] [Related]
38. Increased prevalence of metabolic syndrome in individuals with osteoarthritis: an analysis of NHANES III data.
Puenpatom RA; Victor TW
Postgrad Med; 2009 Nov; 121(6):9-20. PubMed ID: 19940413
[TBL] [Abstract][Full Text] [Related]
39. Prevalence of conventional and lupus-specific risk factors for cardiovascular disease in patients with systemic lupus erythematosus: A case-control study.
Bessant R; Duncan R; Ambler G; Swanton J; Isenberg DA; Gordon C; Rahman A
Arthritis Rheum; 2006 Dec; 55(6):892-9. PubMed ID: 17139666
[TBL] [Abstract][Full Text] [Related]
40. Associations between intracranial haemorrhage and prescribed prophylaxis in a large cohort of haemophilia patients in the United States.
Witmer C; Presley R; Kulkarni R; Soucie JM; Manno CS; Raffini L
Br J Haematol; 2011 Jan; 152(2):211-6. PubMed ID: 21114482
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
